Stockholm Stock Exchange | Mid Cap
Xvivo Perfusion
+76.36%
Latest
+76.36%
3 months
Pareto SecuritiesBryan GarnierDanske BankCarnegieDanske Bank Markets

Price Targets For Xvivo Perfusion

AnalystPrice TargetDateUpside
Pareto Securities291 SEKSep 22
+76.36%
Bryan Garnier400 SEKFeb 2
Danske Bank423 SEKOct -21
Carnegie450 SEKOct -21
Danske Bank Markets448 SEKJun -21

About The Company

XVIVO is a medical technology company firmly rooted within medical science with more than 20 years of experience in the transplantation area.
Xvivo Perfusion